In 62 men with non-metastatic prostate cancer on radiotherapy plus ADT, leuprolide vs relugolix was associated with a greater 12-month increase in coronary total plaque volume (+68.9 mm3; P=.02), driven by noncalcified plaque.
RCTn = 65
Patel et al. Coronary Plaque Progression After Androgen Deprivation Therapy in Men With Prostate Cancer: A Randomized Clinical Trial